Literature DB >> 9488685

Interaction of beta-lactam antibiotics with histidine residue of rat H+/peptide cotransporters, PEPT1 and PEPT2.

T Terada1, H Saito, K Inui.   

Abstract

Peptide transporters mediate the H+-coupled uphill transport of oligopeptides and peptide-like drugs such as beta-lactam antibiotics in the intestinal and renal brush-border membranes. Two H+/peptide cotransporters, PEPT1 and PEPT2, have been cloned and functionally characterized. In this study, we examined the interaction of the dipeptides and beta-lactam antibiotics with the histidine residue of rat PEPT1 and PEPT2 transfected into the renal epithelial cell line LLC-PK1. Diethylpyrocarbonate (DEPC), which is a histidine residue modifier, abolished the glycylsarcosine uptake by both transfectants. The DEPC-induced inhibition of glycylsarcosine uptake via PEPT1 or PEPT2 was attenuated by an excess of dipeptide or aminocephalosporin. In contrast, anionic cephalosporins without an alpha-amino group and bestatin, which is an antineoplastic drug with a beta-amino group, did not attenuate the DEPC-induced inactivation of PEPT1 and PEPT2. The DEPC inactivation of PEPT1 was almost prevented by various charged dipeptides, which suggests that the inability of the drugs without an alpha-amino group to prevent the DEPC inactivation was not due to their ionic charge. These findings suggest that the alpha-amino group of beta-lactam antibiotics interacts with the histidine residue of PEPT1 and PEPT2 and may be involved in the mechanism of substrate recognition by the peptide transporters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488685     DOI: 10.1074/jbc.273.10.5582

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition.

Authors:  T Terada; H Saito; K Sawada; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

Review 2.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

3.  Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.

Authors:  D A Groneberg; P R Eynott; F Döring; Q Thai Dinh; T Oates; P J Barnes; K F Chung; H Daniel; A Fischer
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

4.  Cysteinyl-glycine reduces mucosal proinflammatory cytokine response to fMLP in a parenterally-fed piglet model.

Authors:  Matthew G Nosworthy; Janet A Brunton
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

5.  Computational modelling of H+-coupled peptide transport via human PEPT1.

Authors:  Megumi Irie; Tomohiro Terada; Toshiya Katsura; Satoshi Matsuoka; Ken-ichi Inui
Journal:  J Physiol       Date:  2005-03-31       Impact factor: 5.182

6.  Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.

Authors:  Miyako Okamura; Tomohiro Terada; Toshiya Katsura; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.

Authors:  Tomomi Uchiyama; Ashutosh A Kulkarni; Daryl L Davies; Vincent H L Lee
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

8.  Site-directed mutagenesis of Arginine282 suggests how protons and peptides are co-transported by rabbit PepT1.

Authors:  Myrtani Pieri; Dashiell Hall; Richard Price; Patrick Bailey; David Meredith
Journal:  Int J Biochem Cell Biol       Date:  2007-10-16       Impact factor: 5.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.